Innovation Pharmaceuticals Inc (IPIX)

[sox040713]

The cancellation of the K-AML trial was due to lack of funding. It happened when the EU was in a financial crisis (Greece just filed bankruptcy if I remember correctly). Why would the Italians continued the preclinical study and published the results last year if they were no longer interested?

http://learningcenter.ehaweb.org/eha/2017/22nd/180680/roberta.napolitano.kevetrin.preclinical.study.of.a.new.compound.in.acute.html

While you point to one cancellation, I can point to 8 active/completed trials. I think you would agree that 100% of the scams either failed miserably in trials or couldn't even start one trial. Why would Leo choose the most difficult way which involves collusion with bankruptcy court and FDA, succeeding in all 7 trials and getting 20 CDAs?